{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:00:04Z","timestamp":1789390804803,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.humimm.2015.09.010","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:52:44Z","timestamp":1443228764000},"page":"644-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural killer cells in patients with polycythemia vera"],"prefix":"10.1016","volume":"76","author":[{"given":"Carole","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien G.","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabie","family":"Chelbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Rihet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Le Treut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"S\u00e9bahoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Venton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis T.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2015.09.010_b0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.humimm.2015.09.010_b0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fimmu.2013.00459","article-title":"Natural killer cells modulation in hematological malignancies","volume":"4","author":"Baier","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2015.09.010_b0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2015.09.010_b0020","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3588::AID-IMMU3588>3.0.CO;2-O","article-title":"Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity","volume":"29","author":"Caron","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2015.09.010_b0025","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.emboj.7601570","article-title":"Trogocytosis-based generation of suppressive NK cells","volume":"26","author":"Caumartin","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.humimm.2015.09.010_b0030","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood.V86.10.3869.bloodjournal86103869","article-title":"Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1","volume":"86","author":"Cave","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.09.010_b0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00432-008-0492-1","article-title":"Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells","volume":"135","author":"Chang","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.humimm.2015.09.010_b0040","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood-2002-04-1172","article-title":"BCR\/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs)","volume":"101","author":"Chiorean","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.09.010_b0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2009.12.009","article-title":"Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells","volume":"135","author":"Cognet","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.09.010_b0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/imm.12082","article-title":"Differential expression of natural killer cell activating receptors in blood versus bone marrow in patients with monoclonal gammopathy","volume":"139","author":"Costello","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2015.09.010_b0055","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","article-title":"Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia","volume":"99","author":"Costello","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.09.010_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2006-03-007146","article-title":"Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis","volume":"109","author":"Delhommeau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.09.010_b0065","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/1097-0142(19890901)64:5<1038::AID-CNCR2820640513>3.0.CO;2-W","article-title":"Decreased natural killer (NK) activity in patients with myeloproliferative disorders","volume":"64","author":"Froom","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.humimm.2015.09.010_b0070","first-page":"136","article-title":"Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity","volume":"12","author":"Gersuk","year":"1993","journal-title":"Nat. Immun."},{"key":"10.1016\/j.humimm.2015.09.010_b0075","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1158\/1078-0432.CCR-10-1114","article-title":"Direct effects of type I interferons on cells of the immune system","volume":"17","author":"Hervas-Stubbs","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2015.09.010_b0080","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2015.09.010_b0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2404080","article-title":"Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2015.09.010_b0090","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1182\/blood-2010-08-258772","article-title":"The renaissance of interferon therapy for the treatment of myeloid malignancies","volume":"117","author":"Kiladjian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.09.010_b0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2141.2007.06497.x","article-title":"The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders","volume":"136","author":"Larsen","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.humimm.2015.09.010_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jlb.58.2.249","article-title":"Regulation of NK cells through the 80-kDa TNFR (CD120b)","volume":"58","author":"Mason","year":"1995","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2015.09.010_b0105","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.leu.2405050","article-title":"HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera","volume":"22","author":"Menier","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2015.09.010_b0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2164-4-32","article-title":"Molecular cloning, genomic characterization and over-expression of a novel gene, XRRA1, identified from human colorectal cancer cell HCT116Clone2_XRR and macaque testis","volume":"4","author":"Mesak","year":"2003","journal-title":"BMC Genomics"},{"key":"10.1016\/j.humimm.2015.09.010_b0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2015.09.010_b0120","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1093\/nar\/25.24.5025","article-title":"HUB1, a novel Kruppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expression","volume":"25","author":"Okumura","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2015.09.010_b0125","doi-asserted-by":"crossref","first-page":"637","DOI":"10.5604\/17322693.1058897","article-title":"Effect of allograft inflammatory factor-1 gene polymorphisms on rheumatoid arthritis treatment with methotrexate","volume":"67","author":"Pawlik","year":"2013","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.humimm.2015.09.010_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-010-0898-x","article-title":"Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity","volume":"60","author":"Sanchez","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.humimm.2015.09.010_b0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2015.09.010_b0140","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2015.09.010_b0145","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/carcin\/bgs188","article-title":"Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility","volume":"33","author":"Wei","year":"2012","journal-title":"Carcinogenesis"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915004474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915004474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T20:27:36Z","timestamp":1599596856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885915004474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0198885915004474"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2015.09.010","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cells in patients with polycythemia vera","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2015.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}